Current positions
Since 2023: Co-Scientific Coordinator of the "Global Approach for Health" program ("SOUND - SOrbonne University for a New Deal" project) – Alliance Sorbonne Université.
Since 2022: Scientific Coordinator of the French-Indian Campus "Integrated Health" –Sorbonne Université/Indian Institute of Technology Delhi.
Since 2022: Director Education Institute of Oncology – APHP.6-Sorbonne University, Paris, France.
Since 2020: Head and co-Founder of the Biomedical Humanities Initiative – Sorbonne University, Paris, France.
Since 2015: Head and Founder of the Bachelor Degree in Innovative Public Health Science – Faculty of Science and Engineering, Sorbonne University, Paris, France.
Since 2014: Full Professor in Cell Biology and Genetics (Sorbonne University), Research Centre Saint-Antoine – INSERM UMR_S 938 & SU Paris, France
Since 2014: Co-head and co-Founder of the Interdisciplinary Ph.D. Program in Oncology – Institute of Oncology – Faculty of Medicine, Sorbonne University, Paris, France.
Previous positions
2008-2014: Assistant Professor in Cell Biology and Genetics (University Pierre et Marie Curie), Research Centre Saint-Antoine – INSERM UMR_S 938 & UPMC Paris, France
2007-2008: Universidade Federal do Rio Grande do Sul, Porto Alegre, Brazil (Visiting Professor)
2004-2007: INSERM U673, Hospital Saint-Antoine, Paris, France (Post-doctoral Fellow)
2001-2004: University of Oxford, Sir William Dunn School of pathology, Oxford, United-Kingdom (Post-doctoral Fellow)
2000-2001: Commissariat à l'Energie Atomique, Gif-sur-Yvette, France (Military Service)
1995-2000: Institute Gustave-Roussy, Villejuif, France (Ph. D.).
Current editorial activity
Since 2020: Editor-in-Chief, section "Cancer Therapy" – Cancers (ISSN: 2072-6694).
Since 2019: Member of the Editorial Board – Cancers (ISSN: 2072-6694).
Since 2016: Member of the International Editorial Board – Tumori Journal (ISSN: 0300-8916).
Current advisory committees
Since 2022: Coordinator Life Sciences & Health – COFECUB.
Since 2021: Member of the Board of Directors – Sorbonne University.
Since 2019: Member of the Board for strategic guidance of the Institute of Oncology – APHP.6-Sorbonne University.
My work is focused on the interplay between cancer biology and therapeutics. It concerns the development of novel anticancer agents and combinations and their associated biomarkers based on a mechanistic understanding. This includes both DNA-targeted agents and drugs targeting oncogenic signaling pathways.